Press Releases Successful Completion of 2nd Dose Cohort in CLTX CAR T Trial Read More » December 2021
Press Releases CHM Transforms Portfolio with a Natural Killer Cell Platform Read More » November 2021
Press Releases CHM 1101 (CLTX CAR T) data shows regional control of tumour recurrence Read More » November 2021
Press Releases CHM 1101 (CLTX CAR T) Presents Positive Initial Phase 1 Clinical Data Read More » November 2021
Press Releases Chimeric achieves first milestone on path to CDH17 CAR T clinical trial Read More » October 2021